A zoonosis is defined as an infectious disease transferred between humans and animals. Salmonella and campylobacter spring to mind. They are the tip of the iceberg. Influenza, the 20th century serial killer, and HIV are more compelling examples of zoonoses. HIV and influenza crossed over the border with catastrophic consequences for humanity.
[button link=”http://thecrohnsinfection.org/the-circus-comes-to-town” type=”big”] Read Full Article[/button]
For the last 20 years, a dedicated group of Doctors and Researchers have been studying the pathogen Mycobacterium avium ssp paratuberculosis and its relationship to Crohn’s disease and other diseases termed “autoimmune” diseases. For years, the prevailing view was that IBD was an autoimmune disease, which ...
Inflammatory Bowel Disease (IBD) is a broad term that describes conditions with chronic or recurring immune response and inflammation of the gastrointestinal tract. The two most common inflammatory bowel diseases are ulcerative colitis and Crohn’s disease. In Crohn’s disease, inflammation can affect the entire digestive tract but is usually centered in the ileum (the final segment of the small intestine) and the beginning part of the colon (large intestine). Ulcerative colitis presents exclusively in the colon. Both illnesses are characterized by an abnormal response to the body’s immune system. They can occur at any age, but often initially develop in teenagers and young adults.
Watch as Phil lays out the research and controversy surrounding the anti-MAP treatment as he experiences it first hand.
The video shown here amplifies one success story and provides a nice overview of what is being done, some of the issues surrounding this treatment protocol and why the current medical professionals are reluctant to embrace this treatment.
[button link=”http://thecrohnsinfection.org/the-crohns-controversy” type=”big”] Click here to watch the video and view related links[/button]
John Aitken is a free-lance microbiologist based out of Christchurch, New Zealand and the senior director of Otakaro Pathways, Ltd. Prior to his current position, he has worked in medical microbiology for public and private providers for more than 40 years. In his “spare time” he has established a microbiological environmental testing laboratory.
His particular areas of interest are antimicrobial resistance and emerging bacterial infectious diseases. The majority of his work involves an understanding of the underlying relationships between microorganisms, plants, and animals.
